This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting neurological disorders, particularly those involving dopamine regulation, such as Parkinson's disease and schizophrenia. Its structural features make it a valuable building block for creating molecules that interact with specific receptors in the brain. Additionally, it is explored in research for its potential applications in designing novel antidepressants and anxiolytics due to its ability to influence neurotransmitter systems. Its fluorophenyl group enhances its binding affinity to biological targets, making it a key component in medicinal chemistry.